Lipoprotein apheresis: utility, outcomes, and implementation in clinical practice: a scientific statement from the American Heart Association
Gianos E, Duell PB, Toth PP, et al. Arteriosclerosis, Thrombosis, and Vascular Biology, 2024.
- Study type
- Narrative review
- People studied
- No participants of its own (narrative review)
- Published
- 2024, Arteriosclerosis, Thrombosis, and Vascular Biology
- Identifiers
- PMID 39370995, DOI 10.1161/ATV.0000000000000177
What the authors reported
An American Heart Association statement on lipoprotein apheresis, an FDA-regulated extracorporeal procedure shown to substantially lower LDL cholesterol and lipoprotein(a) through a specific filtration mechanism.
What limits this result
Reviews an established, evidence-graded procedure for cholesterol removal; does not evaluate EBO2 or claim that EBO2's filter achieves comparable, measured lipid removal.
How ozone acts on blood and cells, how blood filters work, and studies that measure markers in the blood rather than how patients fare. None of these shows whether EBO2 helps patients. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.
Where we cite this study
What Does the EBO2 (EBOO) Filter Actually Remove?
EBO2 (EBOO) clinics say the filter removes toxins, cholesterol, and heavy metals. Here is what the device's pore size allows and what has been measured.